Toxicity Estimation of Unspecific Medicinal Antiviral Agents for Prophylaxis and Therapy of Hazard and Especially Hazard Viral Infections
Abstract
Cytotoxicity of chemotherapeutics (Ribavirin®, Remantadin® and Ingavirin®), interferon (Realdiron®) and interferon inductors (Larifan®, Ridostin®, Arbidol® and Cytarabin®) was investigated with the use of persistent and diploid cell cultures. Ingavirin® and Ribavirin® from the group of the chemotherapeutics and Razifan® and Ridostin® from the group of the interferon inducrors showed the lowest toxicity. Light microscopy revealed no visible cytopathic changes in the investigation cell cultures exposed to maximum concentrations (≥106 IU) of Realdiron®. In vivo acute toxicity investigation demonstrated that in a concentration of 106 IU per animal weight Realdiron® was not toxic for the albino mice and chinchilla rabbits. The maximum tolerance doses for the albino mice were the following: ≥3000 mg/kg of Ingavirin®, 401.25 mg/kg of Arbidol®, 170 mg/kg of Ribavirin®, ≥100 mg/kg of Larifan® and ≥100 mg/kg of Ridostin®.
Conflicts of Interest Disclosure:
The authors declares that there is no conflict of interest.
Article info:
Date submitted: 13.05.2020
All authors have read and approved the final manuscript.
Peer review info:
"Antibiot Khimioter = Antibiotics and Chemotherapy" thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Editorial comment:
In case of any discrepancies in a text or the differences in its layout between the pdf-version of an article and its html-version the priority is given to the pdf-version.
About the Authors
S. YA. Loginova
Branch of Central Research Institute No. 48, Ministry of Defense of the Russian Federation, Virological Centre, Sergiev Posad
Russian Federation
S. V. Borisevich
Branch of Central Research Institute No. 48, Ministry of Defense of the Russian Federation, Virological Centre, Sergiev Posad
Russian Federation
V. A. Maksimov
Branch of Central Research Institute No. 48, Ministry of Defense of the Russian Federation, Virological Centre, Sergiev Posad
Russian Federation
V. P. Bondarev
Branch of Central Research Institute No. 48, Ministry of Defense of the Russian Federation, Virological Centre, Sergiev Posad
Russian Federation
References
1. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. М., 2005.
2. Соловьев В.Д., Бектемиров Т.А. Интерферон в теории и практике медицины. М., 1981.
3. Еропкин М.Ю., Еропкина Е.М. Культуры клеток как модельная система исследования токсичности и скрининга цитопротекторных препаратов. СПб, 2003. 239.
4. Чижов Н.П., Носков Ф.С. Схема первичного отбора противовирусных препаратов // Молекулярная биология вирусов, химиотерапия и химиопрофилактика вирусных инфекций. Минск, 1974. 217-219.
5. Носков Ф.С., Демченко В.М., Соколова Е.Д. и др. // Методические вопросы научной разработки противовирусных средств. Минск, 1977. 49-55.
For citations:
Loginova S.Ya.,
Borisevich S.V.,
Maksimov V.A.,
Bondarev V.P.
Toxicity Estimation of Unspecific Medicinal Antiviral Agents for Prophylaxis and Therapy of Hazard and Especially Hazard Viral Infections. Antibiot Khimioter = Antibiotics and Chemotherapy. 2009;54(3-4):11-14.
(In Russ.)
Views:
694